Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
  • A61Q19/06—Preparations for care of the skin for countering cellulitis
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
  • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/60—Sugars; Derivatives thereof
  • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/67—Vitamins
  • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
  • A61K8/67—Vitamins
  • A61K8/678—Tocopherol, i.e. vitamin E
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
  • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
  • A61K8/9706—Algae
  • A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
  • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
  • A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
  • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
  • A61K8/9783—Angiosperms [Magnoliophyta]
  • A61K8/9789—Magnoliopsida [dicotyledons]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
  • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
  • A61K8/9783—Angiosperms [Magnoliophyta]
  • A61K8/9794—Liliopsida [monocotyledons]
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin

Definitions

• Cosmetic body treatment method for improving the silhouette and development of the female bust, and binary cosmetic composition for its implementation is a cosmetic body treatment method for improving the silhouette and development of the female bust, and binary cosmetic composition for its implementation.
• the invention relates to a method of cosmetic treatment of the body to improve the silhouette, and / or to develop parts of the bust such as the breasts.
• the subject of the invention is also a binary cosmetic composition or cosmetic complex consisting of two products, the joint use of which has the effect of increasing the volume of areas deemed to be too small or of too small size such as that of the breasts, while decreasing the volume of an area deemed too large, for example that of the hips.
• estrogenic hormones or phytoestrogens can be considered but poses a potential risk and is prohibited in cosmetics in certain countries (list of substances whose use in cosmetic products and personal care products is subject to ban on Annex II of the modified Cosmetic Directive 76/768 / EEC: estrogens and substances with effect).
• Fat synthesis promoters have been proposed (JP-11199499) to allow breast augmentation.
• This solution which is better than the previous ones, however has the drawback of increasing the total fat mass of the person using it, which is not generally sought after. Efficiency is also low, and is reduced to the ability of breast tissue to synthesize this fat.
• the binary composition according to the invention used according to the treatment method according to the invention turns out to be of a definite advantage for solving problems such as those disproportionate breasts (one breast larger than the other).
• the lipolytic product is applied to the larger breast and / or the hips and the other product to the smaller breast.
• the present invention therefore relates to a method of cosmetic treatment of the body intended to improve the silhouette, characterized in that, on the one hand, it is applied to a first zone the volume of which is to be reduced (for example the hips or the breast the largest in the case of disproportionate breasts), a product with lipolytic properties in order to cause lipolysis of the fats contained in the adipocytes of the tissues concerned (such as the hips, ...), and, on the other hand, on a second zone, the volume of which is to be increased (for example the breast or breasts), a product endowed with lipogenetic properties so as to effect a capture and a fixation, in said second zone, of the fats released by the application of the lipolytic product.
• a first zone the volume of which is to be reduced (for example the hips or the breast the largest in the case of disproportionate breasts)
• a product with lipolytic properties in order to cause lipolysis of the fats contained in the adipocytes of the tissues concerned (such as the hip
• the present invention relates to a method of cosmetic treatment of the body intended to develop the bust, by applying on the one hand on an adipose zone of the body, a product endowed with lipolytic properties in order to cause a lipolysis of the fats contained in the adipocytes of the tissues of the zone concerned, and on the other hand, on the part or parts of the bust that l 'We wish to develop a product endowed with lipogenetic properties or an ability to capture the fats released by the application of the lipolytic product and to fix them in said parts of the bust.
• the present invention also relates to a binary cosmetic composition or cosmetic complex for the implementation of this process, consisting on the one hand, of a product endowed with lipolytic properties intended to be applied to an adipose area of the body, and d 'on the other hand, of a product endowed with lipogenetic properties or an ability to capture fats and to fix them, intended to be applied on the part or parts of the bust which one wishes to develop.
• the cosmetic complex according to the invention causes, on the one hand, lipolysis of the fats contained in the adipocytes of the tissues, preferably those of the hips (the presence of which is generally abundant at this level in women, and considered unsightly), and , on the other hand, a capture and fixation of the fats thus released, preferably at the breasts to increase the volume.
• the product having lipolytic properties preferably, although in no way limiting, contains xanthines, and in particular caffeine or even alpha-tocopherol nicotinate, cola extract, carnitine, vitamin E and its acetate, blockers of alpha 2 receptor such as Ginkgo biloba, inhibitors of NPY receptors such as Enteromorpha compressa extract and any other lipolytic agent capable of releasing fat from adipocytes.
• oily plant extracts including: • Climbing ivy extract (Hedera helix), for example obtained by prolonged maceration of the leaves in propylene glycol;
• Arnica extract (Arnica montana L), for example obtained by maceration of arnica flower heads in glycol or in apricot kernel oil
• Rosemary extract (Rosmarinus officinalis N), for example obtained by prolonged maceration of the leaves in glycol or apricot kernel oil
• Marigold extract Calendule officinalis, for example obtained by prolonged maceration of flowers in glycol or apricot kernel oil;
• St. John's wort extract for example obtained from flowers by maceration in neutral oil or in glycol;
• the extract of fragon for example obtained from rhizomes of fragon (Ruscus aculeatus L), previously ground and extracted using an aqueous-alcoholic solution of an alcohol having 3 to 6 carbon atoms preferably in l using water-saturated n-butanol;
• Ulmaire extract (Filipendula ulmaria L), for example obtained by prolonged maceration of the whole plant in neutral oil or in isopropyl myristate; • Orthosiphon extract (Ortosifon stamincus benth), for example obtained by prolonged maceration of flower heads in neutral oil;
• the algae extract for example obtained by prolonged maceration of the whole plant in an oxyethylenated oil
• water-soluble plant extracts including: The water-soluble extract of algae, hydroglycolic extract obtained, by for example, by prolonged maceration of fronds in a solution of hydroglycolic extract;
• the water-soluble birch extract (Betula alba) obtained, for example, by prolonged maceration of bark in a solution of hydroglycolic extract;
• hydro-alcoholic plant extracts including the hydro-alcoholic extract of cola nuts (Cola Nipida), for example obtained by leaching seeds with alcohol;
• the product intended to capture and fix the fats released after lipolysis, or “lipogenetic” product preferably contains, although in no way limiting, adenosine and / or vitamin A and / or Pro-retinol and / or Ginseng like any other another substance capable of retaining fat in breast adipocytes, among which there may be mentioned insulin-like substances or any factor of the IGF type (insulin growth factor).
• the cosmetic complex according to the invention can be in different forms, in particular in the form of an oil-in-water emulsion.
• the lipogenetic product is composed of:
• Macadamia oil 0.5 g
• this product is composed of:
• Carboxypolymethylene or Carboxylic polymer 0.40 g - Diethanolamine cetyl phosphate 1.50 g
• Macadamia oil 0.50 g
• Ginseng extract (Ginseng panax) 0.20 g
• Carbopol 981 (marketed by Goodrich) 0.2 g - Triethanolamine 0.2 g
• Ginseng extract 0.5 g
• Fragon glycine (Ruscus aculeatus) 1 g - Demineralized water qs 100 g
• the above embodiments can advantageously be used on the breasts in order to increase the volume.
• the following embodiment can be applied to all zones whose volume must be increased:
• Orthosifon extract (Ortosifon stamincus) 1 g
• one embodiment of the product with lipolytic property contains:
• Keto-stearyl alcohol 1.50 g
• Preservative 0.30 g
• Carbopol 981 (marketed by Goodrich) 0.6 g
• the above embodiments can advantageously be used on the hips in order to reduce the volume.
• the following embodiment can be applied to any zone whose volume must be reduced:
• This method allows each volunteer to position themselves, for each of the criteria concerned, on a continuous analog scale, unstructured, materialized by a 10 cm line, and comprised between two opposite qualitative criteria.
• the products are distributed to volunteers who apply them once or twice a day, for four weeks at the level of the bust for the lipogenetic product and at the level of the thighs, belly and hips for the lipolytic product. They are instructed to wash their hands thoroughly between the application of the two products.
• the results are expressed by the average of the measurements in cm of the position of the criterion on the given axis.
• volume volume, firmness, hold, slimming, stomach, silhouette and cellulite.
• the embodiment of the invention described below is particularly preferred for the treatment of disproportionate breasts (lipolytic product on the large breast and lipogenetic product on the small breast).

Landscapes

• Life Sciences & Earth Sciences (AREA)
• Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Engineering & Computer Science (AREA)
• Epidemiology (AREA)
• Birds (AREA)
• Biotechnology (AREA)
• Botany (AREA)
• Microbiology (AREA)
• Mycology (AREA)
• Dermatology (AREA)
• Natural Medicines & Medicinal Plants (AREA)
• Chemical & Material Sciences (AREA)
• Biochemistry (AREA)
• Molecular Biology (AREA)
• Cosmetics (AREA)

Applications Claiming Priority (3)

Publications (1)

Family

ID=32050516

Family Applications (1)

Country Status (5)

Families Citing this family (6)

Family Cites Families (6)

• 2002
  • 2002-10-18 FR FR0212999A patent/FR2845912B1/fr not_active Expired - Fee Related
• 2003
  • 2003-10-15 EP EP03778395A patent/EP1551365A1/de not_active Ceased
  • 2003-10-15 WO PCT/FR2003/003045 patent/WO2004037221A1/fr not_active Ceased
  • 2003-10-15 AU AU2003285404A patent/AU2003285404A1/en not_active Abandoned
  • 2003-10-15 RU RU2005115101/14A patent/RU2005115101A/ru not_active Application Discontinuation

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events